Amedisys, Inc. (AMED) Tops Q2 EPS by 3c; Guides FY12 EPS, Revs

August 7, 2012 7:14 AM

Amedisys, Inc. (NASDAQ: AMED) reported Q2 EPS of $0.27, $0.03 better than the analyst estimate ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found